Moria, Nygell G.
HRN: 25-33-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/29/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/29/2024
07/05/2024
IV
800
Q6
Pcap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes